Gain of methylation at IC1 (IC1-GoM), which causes biallelic expression of the insulin growth factor 2 (IGF2) gene and diminished expression of the oncosuppressor H19 gene, accounts for 5 to 10% of BWS cases. This evidence concerns the gene IGF2 and Beckwith-Wiedemann syndrome.